ENDRA Life Sciences Inc.
NDRANASDAQHealthcareDiagnostics & Research

About ENDRA Life Sciences

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Company Information

CEOAlexander Tokman
Founded2007
IPO DateMay 9, 2017
Employees21
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone734 335 0468
Address
3600 Green Court, Suite 350 Ann Arbor, Michigan 48105-1570 United States

Corporate Identifiers

CIK0001681682
CUSIP29273B104
ISINUS29273B5003
EIN26-0579295
SIC3845

Leadership Team & Key Executives

Alexander Y. Tokman
Chief Executive Officer and Chairman
Richard Jacroux
Chief Financial Officer and Secretary
Dr. Jonathan Behr Ph.D.
Co-Founder
Scott Sober
Head of Operations
Ziad Rouag
Head of Regulatory and Clinical Affairs
Idan Steinberg
Head of Engineering